Our Expert in Hong Kong
No results available
Updated: 8 September 2026
Who this guide is for: JV directors, listed issuer counsel, in-house legal teams, company secretaries and investors. Use this guide to understand statutory duties, HKEX impacts, conflict-management processes, liability exposure and practical board documentation for Hong Kong joint ventures.
Joint venture directors Hong Kong stakeholders appoint to represent their interests sit at the centre of a demanding regulatory landscape, in which the HKEX Listing Rules place significant weight on disclosure, board oversight and connected-transaction approval. For anyone accepting a seat on a joint venture board, whether the venture involves two private companies or a listed issuer and its strategic partner, the governance stakes are high. Regulators and courts scrutinise how directors balance the interests of the JV company against those of the shareholder that nominated them, and the margin for procedural error is narrow.
This guide sets out the fiduciary and statutory duties that bind joint venture directors, explains the practical implications of the HKEX regime, and provides board-ready tools for managing conflicts, liability and documentation. It complements our detailed analysis in the HK Joint Ventures Listing Rules 2026 (in-depth) guide.
About this guidance: This article synthesises regulatory obligations and practical drafting guidance for joint venture boards operating in Hong Kong in 2026. It is intended as general information for directors, counsel and company secretaries, not as a substitute for tailored legal advice on a specific transaction. Directors should verify the current text of the relevant rules and legislation, which may be amended from time to time.
Every director on a Hong Kong joint venture board owes duties to the JV company itself, not to the shareholder who nominated them. This is the single most important principle for joint venture directors Hong Kong investors place on boards, and it is where many governance disputes begin. The duties arise from three overlapping sources: the statutory framework in the Companies Ordinance (Cap. 622), the common law of fiduciary obligation, and the contractual architecture created by the shareholders’ agreement (SHA) and the JV company’s articles.
The Companies Ordinance (Cap. 622) codifies the core standard of care expected of directors. It requires a director to exercise reasonable care, skill and diligence, measured by a dual objective and subjective test: the general knowledge, skill and experience reasonably expected of a person carrying out the director’s functions, together with any additional knowledge, skill and experience the particular director actually possesses. A director nominated for financial expertise, for example, will be held to a higher subjective standard on matters within that expertise.
The Ordinance also governs related areas that bear directly on JV boards, including restrictions on how a company may indemnify or exempt directors from liability, requirements around directors’ interests in transactions, and disclosure obligations. The Companies Registry (Hong Kong) publishes practical guidance for directors on these statutory responsibilities and the associated filing obligations, which is a useful starting point for onboarding new appointees.
Layered on top of the statutory standard are the fiduciary duties developed at common law. These require a director to act in good faith in what they honestly consider to be the interests of the company, to exercise powers for their proper purpose, to avoid conflicts between personal or third-party interests and the interests of the company, and not to profit from their position without informed consent. For joint venture directors Hong Kong companies appoint, the duty to avoid conflicts is the most operationally challenging. A director frequently sits on the JV board precisely because they hold a role, often a senior one, with the nominating shareholder.
That dual capacity is not unlawful, but it demands rigorous management, because the director cannot subordinate the JV company’s interests to those of their appointer.
The shareholders’ agreement and the articles of association can impose bespoke obligations that go beyond the statutory and common-law baseline. These commonly include reserved-matter approval thresholds, information-sharing rights, deadlock-resolution mechanics, and specific conflict-management protocols. A well-drafted JV board charter operationalises these obligations, translating high-level SHA principles into concrete meeting, quorum and voting procedures. Importantly, contractual duties can supplement statutory duties but cannot validly contract out of them where the statute or public policy prohibits it, a point that recurs in the sections on conflicts and indemnities below.
Because the three sources of duty overlap, directors benefit from a clear duty map. A practical mapping exercise should record, for each material decision type:
Where a joint venture involves a listed issuer, or where a listed company is a shareholder in the JV, the HKEX Listing Rules add a layer of disclosure and approval obligations on top of the general duties described above. These rules impose director-level expectations around transaction disclosure and board oversight, and directors representing listed parties should treat compliance as a board-level priority rather than a back-office formality. Because the Listing Rules are updated periodically, directors and their advisers should confirm the current text and any recent amendments with listing counsel before acting.
Listing Rule obligations are most commonly engaged where the JV involves a connected person of a listed issuer, or where the JV transaction itself is of a size or nature that requires disclosure or shareholder approval by the listed party. Formation of a joint venture, funding contributions, provision of guarantees, and dealings between the JV and a controlling shareholder can all fall within the connected-transaction and notifiable-transaction regimes. The practical point for directors is that the analysis must happen early, before the JV is signed, because the classification of a transaction dictates the disclosure and approval steps required.
For directors who serve on the board of the listed shareholder as well as the JV, the framework heightens the importance of timely disclosure and correctly constituted approvals. Where a director has a material interest in a connected transaction, they will ordinarily be required to abstain from voting at the listed issuer level, and the transaction may need approval by independent shareholders with an independent board committee advising. In practice, boards should place particular emphasis on documented board deliberation and clear audit trails demonstrating that directors identified and managed their interests correctly.
The Securities and Futures Commission (SFC) works alongside HKEX in supervising the listing and corporate-governance framework, and directors should be alert to the possibility of regulatory enquiry where connected-transaction procedures are not properly observed.
Conflicts of interest are structural to the joint venture form. Because directors are typically nominated by shareholders with competing commercial objectives, the question is not whether conflicts will arise but how the board manages them. A disciplined, documented process is the single most effective protection for both the individual director and the venture.
Conflicts on JV boards recur in predictable patterns, and identifying them in advance is half the battle:
The core discipline is prompt, written disclosure. A director who becomes aware of an actual or potential conflict should disclose it to the board and the company secretary as soon as practicable, in writing, and the disclosure should be recorded in the board minutes. A standing conflicts register maintained by the company secretary allows the board to track recurring interests and to refresh disclosures at the start of each meeting. An illustrative conflict disclosure form typically captures the nature of the interest, the transaction or matter to which it relates, the director’s proposed course of action (recusal, abstention, or continued participation), and the date of disclosure.
Any such template should be treated as illustrative and adapted to the specific SHA and charter provisions.
Once a conflict is disclosed, the board must decide how the conflicted director participates. Depending on the charter and SHA, the options range from full recusal (the director leaves the meeting for the relevant item), to abstention from voting while remaining present to answer questions, to continued participation where the interest is not material and the other directors consent on an informed basis. For higher-risk matters, particularly related-party transactions, best practice, consistent with the G20/OECD Principles of Corporate Governance, is to route the decision through independent directors or an independent committee, so that an unconflicted mind approves the transaction on arm’s-length terms.
Where the conflict is acute, where the transaction is significant, or where the board cannot achieve a clean unconflicted quorum, escalation is prudent. This may mean referring the matter to shareholders under a reserved-matter provision, obtaining an independent fairness opinion, or taking external legal advice on the proper procedure. Documenting the reasons for escalation and the advice received strengthens the board’s position if the decision is later challenged.
Directors who fail to observe their duties face civil claims, regulatory consequences and, in narrow circumstances, criminal exposure. Understanding the shape of that risk helps joint venture directors calibrate their conduct and their protective arrangements.
In the joint venture setting, claims frequently arise from allegations that a director preferred the interests of the nominating shareholder over those of the JV company, approved a related-party transaction on non-arm’s-length terms, failed to disclose a conflict, or breached the duty of care in approving a transaction without adequate diligence. Minority shareholders in a JV are a common source of complaint, and the mechanisms available to them include petitions for relief from unfair prejudice and, where the company itself will not act, derivative claims brought on the company’s behalf.
Hong Kong courts have repeatedly addressed director conflicts, breaches of fiduciary duty and derivative actions, and the Judiciary of the HKSAR judgments database is the authoritative source for the reasoning in specific decisions. Directors and their advisers should review the current case law when assessing a live risk, because the courts’ treatment of informed consent, ratification and the proper-purpose doctrine continues to develop. In practice, the enforcement environment places significant weight on procedural rigour, courts and regulators may ask not only whether a decision was substantively fair but whether the board followed a defensible process in reaching it.
Practical exposure is not limited to the direct financial consequences of a claim. Directors face the cost and management distraction of litigation, potential reputational damage, and the possibility of regulatory action where a listed party is involved. Because limitation and procedural rules vary by cause of action, directors facing a potential claim should take advice promptly rather than assume that the passage of time has extinguished exposure.
Given the liability landscape, joint venture directors Hong Kong appointees should ensure that indemnity and insurance protections are in place before they act, not after a claim emerges. Two mechanisms do most of the work: contractual indemnities and directors’ and officers’ (D&O) liability insurance.
The Companies Ordinance (Cap. 622) permits companies to indemnify directors in certain respects but restricts the extent to which a company may exempt a director from, or indemnify a director against, liability for negligence, default, breach of duty or breach of trust in relation to the company. The practical consequence is that an indemnity cannot lawfully immunise a director against liability to the company for their own wrongdoing. What indemnities commonly and validly cover is defence costs and liabilities to third parties, subject to the statutory carve-outs.
An illustrative indemnity clause should therefore be carefully scoped to fall within the permitted boundaries, and should be reviewed against the current statutory text before adoption; treat any sample wording as a starting point rather than a settled form.
D&O insurance is the practical backstop where an indemnity is unavailable or the indemnifying company lacks the funds to honour it. The critical drafting question for JV directors is whether the policy responds to acts done in their capacity as a director of the joint venture entity, an “outside directorship” that may not be automatically covered under a policy written for the nominating shareholder. Directors should confirm that the policy wording extends to JV activities, consider specific endorsements addressing related-party exposures, and scrutinise carve-outs that could exclude the very conflicts most likely to give rise to a claim.
Both indemnities and insurance need to be properly authorised and funded. The SHA and JV board charter should specify who bears the cost of the D&O premium, how indemnities are approved, and whether the JV or the nominating shareholders stand behind them. Aligning the insurance arrangements with the JV funding agreement avoids gaps where a director assumes they are covered but the funding responsibility was never allocated.
A robust JV board charter is the document that converts duties and rules into day-to-day practice. It should be tailored to the specific venture, but certain clauses are effectively mandatory for a well-governed board.
A practical clause bank, covering board composition, quorum, voting, independent-director involvement and the conflict policy, allows a JV to assemble a charter quickly while preserving consistency with the SHA. The table below summarises how the principal duties and requirements map across the different sources that bind joint venture directors Hong Kong boards must reconcile, together with the practical control that manages each one.
| Duty / Requirement | Source | Applicability to JV directors | Practical control |
|---|---|---|---|
| Duty to act in good faith / for the company’s benefit | Companies Ordinance / common law | Applies to the JV company and its directors, but directors must navigate multiple principals | Clear duty mapping in the board charter; conflict disclosure |
| Duty to avoid conflicts | Common law and Listing Rules (where a listed party is involved) | High risk in JVs where directors represent shareholders | Written conflict policy; recusal rules |
| Listing Rules disclosure / connected-transaction approval | HKEX Listing Rules | Applies where a party is listed or the deal affects a listed issuer | Early listing counsel review; independent board committees |
| Contractual duties under the SHA / Articles | JV SHA / Articles of association | Parties can create bespoke obligations and indemnities | Ensure clauses do not contravene public policy or statute |
Compared with a standard private-company board terms of reference, a JV charter places far greater weight on conflict management, reserved matters and independent decision-making, precisely because the directors owe divided loyalties that a wholly-owned subsidiary board does not face.
The following action plan helps both incoming and serving directors discharge their duties and protect their position:
The current regulatory environment makes disciplined governance non-negotiable for joint venture directors Hong Kong companies and investors appoint to represent their interests. The essential message is straightforward: your duty runs to the JV company, conflicts must be disclosed and managed through documented procedures, listed-party transactions demand early classification and correctly constituted approvals, and your protective arrangements, indemnities and D&O insurance, should be in place and properly funded before you act. Directors who combine a clear duty map, a robust board charter and rigorous minute-keeping put themselves in the strongest position to withstand regulatory scrutiny and shareholder challenge.
For a deeper analysis of the transactional dimension, read our companion HK Joint Ventures Listing Rules 2026 (in-depth) guide, and seek tailored legal advice before finalising any JV governance documentation.
This article was produced by Global Law Experts. For specialist advice on this topic, contact Timothy Lam at Long An & Lam LLP, a member of the Global Law Experts network.
posted 4 minutes ago
posted 4 minutes ago
posted 6 minutes ago
posted 13 minutes ago
posted 13 minutes ago
posted 21 minutes ago
posted 22 minutes ago
posted 22 minutes ago
posted 35 minutes ago
posted 35 minutes ago
posted 37 minutes ago
posted 43 minutes ago
No results available
Find the right Legal Expert for your business
Send welcome message